# US 2020/0138736 A1 · Cannabidiol formulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0138736 A1
- Document ID: US20200138736A1
- Status: Published application
- Kind: A1
- Application number: 16/556,149
- Filed: 2019-08-29
- Published: 2020-05-07
- Earliest claimed: 2018-11-06
- Assignees: Healthy Roots Inc.
- Applicants: Healthy Roots Inc.
- Inventors: Elizabeth Merritt
- Web page: https://patentgrep.com/patent/US20200138736A1

## CPC

- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 36/3482: {Cannabis}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Cannabidiol (CBD) formulation comprising a mixture of full spectrum cannabidiol oil (FSO) and cannabidiol isolate (CBD isolate) is disclosed. The formulation contains a total amount of CBD derived from a combination of an amount of CBD in the FSO and an amount of CBD from the CBD isolate. The formulation of FSO and CBD isolate in used for medicinal and health benefits in a wide range of products, such as tinctures, capsules, creams or lotions, bath salts or bombs, soaps, pet or animal tinctures, and pet or animal edible chews.

## Claims

### Claim 1

A cannabidiol (CBD) formulation comprising full spectrum cannabidiol oil (FSO), and cannabidiol isolate (CBD isolate), wherein the FSO and CBD isolate contribute an amount of CBD to the formulation.

### Claim 2 (depends on 1)

The cannabidiol formulation of claim 1 wherein the ratio of FSO to CBD isolate ranges from 80% FSO and 20% CBD isolate, to 55% FSO and 45% CBD isolate.

### Claim 3 (depends on 1)

The cannabidiol formulation of claim 1 further comprising cannabichromene (CBC).

### Claim 4 (depends on 3)

The cannabidiol formulation of claim 3 further comprising cannabigerol (CBG).

### Claim 5 (depends on 1)

The cannabidiol formulation of claim 1 wherein the amount of CBD is between 60-75% (wt.) of the formulation, and wherein the formulation contains less than 7% (wt.) tetrahydrocannabinol (THC).

### Claim 6 (depends on 2)

The cannabidiol formulation of claim 2 further comprising cannabichromene (CBC), wherein CBC is at least 3% (wt.) of the formulation.

### Claim 7 (depends on 6)

The cannabidiol formulation of claim 6 further comprising cannabigerol (CBG), wherein CBG is at least 0.5% (wt.) of the formulation.

### Claim 8 (depends on 2)

The cannabidiol formulation of claim 2 wherein the formulation is incorporated into a tincture, capsule, lotion, bath salt, lip balm, edible chew, butter, bath bomb, or animal treat.

### Claim 9

A cannabidiol (CBD) tincture comprising approximately 3% (wt.) CBD, full spectrum cannabidiol oil (FSO), and cannabidiol isolate (CBD isolate), wherein the formulation contains less than 0.3% (wt.) tetrahydrocannabinol (THC).

### Claim 10 (depends on 9)

The cannabidiol (CBD) tincture of claim 9 wherein the tincture contains less than 0.25% (wt.) tetrahydrocannabinol (THC).

### Claim 11 (depends on 9)

The cannabidiol (CBD) tincture of claim 9 wherein the tincture contains less than 0.2% (wt.) tetrahydrocannabinol (THC).

### Claim 12 (depends on 9)

The cannabidiol (CBD) tincture of claim 9 wherein the tincture contains less than 0.15% (wt.) tetrahydrocannabinol (THC).

### Claim 13 (depends on 9)

The cannabidiol (CBD) tincture of claim 9 further comprising at least 0.1% (wt.) cannabichromene (CBC).

### Claim 14 (depends on 9)

The cannabidiol (CBD) tincture of claim 9 further comprising at least 0.02% (wt.) cannabigerol (CBG).

### Claim 15 (depends on 9)

The cannabidiol (CBD) tincture of claim 9 wherein the tincture is a berry or mint flavor.

### Claim 16

A method for production of a cannabidiol (CBD) formulation comprising:
obtaining an amount of a full spectrum cannabidiol oil (FSO) containing CBD;
obtaining an amount of a cannabidiol isolate (CBD isolate) containing CBD;
determining by analytical testing the CBD content of the FSO;
determining by analytical testing the CBD content of the CBD isolate;
mixing the FSO and the CBD isolate to produce the formulation, wherein the formulation comprises an amount of CBD, wherein the ratio of FSO to CBD isolate ranges from 80% FSO and 20% CBD Isolate, to 55% FSO and 45% CBD isolate, and wherein the formulation contains less than 7% (wt.) tetrahydrocannabinol (THC).

### Claim 17 (depends on 16)

The method of claim 16 wherein the analytical testing method is high performance liquid chromatography (HPLC) or gas chromatography (GC).

### Claim 18 (depends on 16)

The method of claim 16 further comprising determining the flavor profile of the formulation.

### Claim 19 (depends on 16)

The method of claim 16 further comprising increasing the amount of CBD isolate relative to the amount of FSO to improve the flavor profile.

### Claim 20 (depends on 16)

The method of claim 16 further comprising incorporating the CBD formulation into a tincture, capsule, lotion, bath salt, lip balm, edible chew, butter, bath bomb, or animal treat.
